Results for tag: "Renal Cell Carcinoma Drug"

Renal Cell Carcinoma (RCC) is a type of cancer that affects the kidneys. It is the most common type of kidney cancer in adults, and is typically treated with drugs that target the cancer cells. These drugs are part of the larger market of drugs used to treat liver and kidney disorders. RCC drugs are typically used in combination with other treatments, such as surgery, radiation, and immunotherapy. They are designed to target the cancer cells and stop them from growing and spreading. Common drugs used to treat RCC include tyrosine kinase inhibitors, mTOR inhibitors, and VEGF inhibitors. The RCC drug market is highly competitive, with many companies developing and marketing drugs to treat the disease. Some of the major players in the market include Pfizer, Novartis, Merck, Bristol-Myers Squibb, and AstraZeneca. Show Less Read more